Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7309-7316

  Ray, Manujendra ^a   Yu, Shan ^a   Sharda, Daniel R ^a   Wilson, Caleph B ^a   Liu, Qingping ^a   Kaushal, Naveen ^a   Prabhu, K Sandeep ^a   Hankey, Pamela A ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; MACROPHAGE ACTIVATING FACTOR; MACROPHAGE STIMULATING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; RON RECEPTOR TYROSINE KINASE; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOKINE PRODUCTION; DNA BINDING; FEEDBACK SYSTEM; MACROPHAGE; MOLECULAR DOCKING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; CELL LINE; HEPATOCYTE GROWTH FACTOR; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 78650671081     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000095     Document Type: Article

References (39)

1. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
2. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
3. Correll, P. H., A. C. Morrison, and M. A. Lutz. 2004. Receptor tyrosine kinases and the regulation of macrophage activation. J. Leukoc. Biol. 75:731-737.
4. Lemke, G., and C. V. Rothlin. 2008. Immunobiology of the TAM receptors. Nat. Rev. Immunol. 8:327-336.
5. Chen, Y. Q., J. H. Fisher, and M. H. Wang. 1998. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J. Immunol. 161:4950-4959.
6. Liu, Q. P., K. Fruit, J. Ward, and P. H. Correll. 1999. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 163:6606-6613.
7. Morrison, A. C., and P. H. Correll. 2002. Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J. Immunol. 168:853-860.
8. Correll, P. H., A. Iwama, S. Tondat, G. Mayrhofer, T. Suda, and A. Bernstein. 1997. Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct. 1:69-83.
9. Waltz, S. E., L. Eaton, K. Toney-Earley, K. A. Hess, B. E. Peace, J. R. Ihlendorf, M. H. Wang, K. H. Kaestner, and S. J. Degen. 2001. Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J. Clin. Invest. 108:567-576.
10. Tsutsui, S., F. Noorbakhsh, A. Sullivan, A. J. Henderson, K. Warren, K. Toney-Earley, S. E. Waltz, and C. Power. 2005. RON-regulated innate immunity is protective in an animal model of multiple sclerosis. Ann. Neurol. 57:883-895.
11. Lentsch, A. B., P. Pathrose, S. Kader, S. Kuboki, M. H. Collins, and S. E. Waltz. 2007. The RON receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor kappaB activation. Shock 27:274-280.
12. Morrison, A. C., C. B. Wilson, M. Ray, and P. H. Correll. 2004. Macrophagestimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J. Immunol. 172:1825-1832.
13. Wilson, C. B., M. Ray, M. Lutz, D. Sharda, J. Xu, and P. A. Hankey. 2008. The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity. J. Immunol. 181:2303-2310.
14. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.
15. Lee, E. S., P. Kalantari, S. Tsutsui Section, A. Klatt, J. Holden, P. H. Correll, C. Power Section, and A. J. Henderson. 2004. RON receptor tyrosine kinase, a negative regulator of inflammation, inhibits HIV-1 transcription in monocytes/macrophages and is decreased in brain tissue from patients with AIDS. J. Immunol. 173:6864-6872.
16. Nikolaidis, N., J. Gray, D. Gurusamy, W. Fox, W. Stuart, N. Huber, and S. Waltz. 2010. RON receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and ADAM17 production. Shock 33:197-204.
17. Lutz, M. A., and P. H. Correll. 2003. Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C zeta. J. Leukoc. Biol. 73:802-814.
18. Prabhu, K. S., R. J. Arner, H. Vunta, and C. C. Reddy. 2005. Up-regulation of human myo-inositol oxygenase by hyperosmotic stress in renal proximal tubular epithelial cells. J. Biol. Chem. 280:19895-19901.
19. Vunta, H., F. Davis, U. D. Palempalli, D. Bhat, R. J. Arner, J. T. Thompson, D. G. Peterson, C. C. Reddy, and K. S. Prabhu. 2007. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12, 14-prostaglandin J2 in macrophages. J. Biol. Chem. 282:17964-17973.
20. Teal, H. E., S. Ni, J. Xu, L. D. Finkelstein, A. M. Cheng, R. F. Paulson, G. S. Feng, and P. H. Correll. 2006. GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells. Oncogene 25:2433-2443.
21. Thomas, K. E., C. L. Galligan, R. D. Newman, E. N. Fish, and S. N. Vogel. 2006. Contribution of interferon-beta to the murine macrophage response to the tolllike receptor 4 agonist, lipopolysaccharide. J. Biol. Chem. 281:31119-31130.
22. Saito, S., M. Matsuura, and Y. Hirai. 2006. Regulation of lipopolysaccharideinduced interleukin-12 production by activation of repressor element GA-12 through hyperactivation of the ERK pathway. Clin. Vaccine Immunol. 13:876-883.
23. Wei, X., L. Hao, S. Ni, Q. Liu, J. Xu, and P. H. Correll. 2005. Altered exon usage in the juxtamembrane domain of mouse and human RON regulates receptor activity and signaling specificity. J. Biol. Chem. 280:40241-40251.
24. Wei, X., S. Ni, and P. H. Correll. 2005. Uncoupling ligand-dependent and-independent mechanisms for mitogen-activated protein kinase activation by the murine RON receptor tyrosine kinase. J. Biol. Chem. 280:35098-35107.
25. Buss, H., A. Dörrie, M. Schmitz, E. Hoffmann, K. Resch, and M. Kracht. 2004. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-kappaB at serine 536 is mediated by multiple protein kinases including IkappaB kinase (IKK)-alpha, IKKbeta, IKKepsilon, TRAF family member-associated (TANK) - binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279:55633-55643.
26. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5:392-401.
27. Yamamoto, M., and K. Takeda. 2008. Role of nuclear IkappaB proteins in the regulation of host immune responses. J. Infect. Chemother. 14:265-269.
28. Yamazaki, S., T. Muta, and K. Takeshige. 2001. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 276:27657-27662.
29. Yamamoto, M., S. Yamazaki, S. Uematsu, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Kuwata, O. Takeuchi, K. Takeshige, et al. 2004. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430:218-222.
30. Wetzel, C. C., M. A. Leonis, A. Dent, M. A. Olson, A. M. Longmeier, P. A. Ney, G. P. Boivin, S. A. Kader, C. C. Caldwell, S. J. Degen, and S. E. Waltz. 2007. Short-form RON receptor is required for normal IFN-gamma production in concanavalin A-induced acute liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G253-G261.
31. Narasimhan, M., and S. Ammanamanchi. 2008. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells. Cancer Res. 68:5185-5192.
32. Zhou, Y. Q., Y. Q. Chen, J. H. Fisher, and M. H. Wang. 2002. Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J. Biol. Chem. 277:38104-38110.
33. Ni, S., C. Zhao, G. S. Feng, R. F. Paulson, and P. H. Correll. 2007. A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/RON receptor tyrosine kinase in response to Friend virus infection. Mol. Cell. Biol. 27:3708-3715.
34. El Kasmi, K. C., A. M. Smith, L. Williams, G. Neale, A. D. Panopoulos, A. Panopolous, S. S. Watowich, H. Häcker, B. M. Foxwell, and P. J. Murray. 2007. Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J. Immunol. 179:7215-7219.
35. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7:454-465.
36. Mansell, A., R. Smith, S. L. Doyle, P. Gray, J. E. Fenner, P. J. Crack, S. E. Nicholson, D. J. Hilton, L. A. O'Neill, and P. J. Hertzog. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7:148-155.
37. Frobøse, H., S. G. Rønn, P. E. Heding, H. Mendoza, P. Cohen, T. Mandrup-Poulsen, and N. Billestrup. 2006. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20:1587-1596.
38. Straus, D. S., and C. K. Glass. 2007. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 28:551-558.
39. Lutz, M. A., F. Gervais, A. Bernstein, A. L. Hattel, and P. H. Correll. 2002. STK receptor tyrosine kinase regulates susceptibility to infection with Listeria monocytogenes. Infect. Immun. 70:416-418.